Split Fed. Circ. Upholds Mylan's Win In Axing Tecfidera Patent
A West Virginia federal judge rightfully invalidated a patent covering Biogen's blockbuster multiple sclerosis drug Tecfidera, negating the need to see whether the Patent Trial and Appeal Board should have done...To view the full article, register now.
Already a subscriber? Click here to view full article